APEIRON Capital Ltd’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-237,130
Closed -$8.81M 15
2024
Q3
$8.81M Sell
237,130
-9,990
-4% -$373K 3.14% 7
2024
Q2
$11.8M Sell
247,120
-104,192
-30% -$4.57M 4.11% 4
2024
Q1
$13.4M Sell
351,312
-400
-0.1% -$13K 6.8% 3
2023
Q4
$11M Hold
351,712
16.13% 2
2023
Q3
$14.1M Sell
351,712
-43,441
-11% -$2.03M 9.46% 3
2023
Q2
$20.8M Sell
395,153
-127,872
-24% -$7.79M 12.55% 3
2023
Q1
$33.4M Buy
523,025
+185,386
+55% +$12.1M 18.67% 2
2022
Q4
$16.4M Sell
337,639
-69,461
-17% -$4.36M 15.97% 2
2022
Q3
$28.7M Hold
407,100
19.14% 2
2022
Q2
$28.9M Hold
407,100
17.67% 2
2022
Q1
$32.5M Hold
407,100
14.38% 2
2021
Q4
$37.2M Buy
407,100
+14,100
+4% +$1.51M 10.96% 3
2021
Q3
$50.5M Buy
393,000
+26,000
+7% +$3.64M 13.26% 2
2021
Q2
$56M Hold
367,000
18.11% 2
2021
Q1
$38.7M Buy
367,000
+52,000
+17% +$5.21M 16.63% 3
2020
Q4
$25M Buy
+315,000
New +$23.1M 12.03% 4

Other funds holding STAA

APEIRON Capital Ltd's STAA Position: Q4 2024 in Review

APEIRON Capital Ltd sold out of STAAR Surgical (STAA) in Q4 2024, closing a stake of 237,130 shares — an estimated $8.81M sold.

APEIRON Capital Ltd first reported a position in STAA in Q4 2020 and held it in 16 quarters. The position peaked at $56M in Q2 2021. 212 funds tracked by Wall St. Rank hold STAA as of Q4 2024.

  • APEIRON Capital Ltd reported no remaining STAAR Surgical position as of Q4 2024 after selling out during the quarter.
  • APEIRON Capital Ltd sold 237,130 STAAR Surgical shares in Q4 2024, an estimated $8.81M.
  • APEIRON Capital Ltd first reported a position in STAAR Surgical in Q4 2020 and held it in 16 quarters.
  • APEIRON Capital Ltd's STAAR Surgical position peaked at $56M in Q2 2021.
  • 212 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2024.

Based on APEIRON Capital Ltd's 13F filing for Q4 2024, filed 7 Jan 2025.